Pedicor Trial s.r.o.

The site focuses on cardiovascular diseases, investigating treatments aimed at reducing major adverse cardiac events in patients with established disease or high risk.

• Evaluation of novel oral agents for MACE reduction
• Assessment of cardiovascular outcomes in high‑risk populations
• Study of atherosclerotic disease progression

Pedicor Trial s.r.o. conducts these studies within its cardiology and angiology department, seeking safer and more effective therapies for heart and vascular health.

Research also targets hypertension and its impact on heart failure, testing innovative therapies that may lower blood pressure and prevent cardiovascular death.

• Investigation of RNA‑based treatments for resistant hypertension
• Analysis of hospitalization rates for heart failure
• Comparison of new agents versus placebo in stroke risk reduction

The studies aim to improve management of patients with uncontrolled blood pressure and reduce the burden of cardiovascular complications across Ostrava and beyond.